Skip to content

Inspection Record

Option Care Enterprises Inc. — FDA 483 Findings

US FDAInspected 2017-08-08Published 2024-01-17 8 findingsValidation and qualificationEquipment and facilityMaterial and supplier controlAseptic processing and sterility assuranceOther quality system

View the regulator's official source The source document is always the basis for judgement.

Findings

1Validation and qualification

ISO-5 classified areas were not certified under dynamic conditions.

2Equipment and facility

There is no record for monitoring of pressure differentials between adjacent rooms in the Compounding Area and no record for cleaning when drugs were produced on the weekends.

3Material and supplier control

Placement and/or use of non-sterile material within the ISO 5 area.

4Aseptic processing and sterility assurance

Your media plates for environmental monitoring and personnel monitoring were not incubated appropriately to ensure your production process and production facility do not have insanitary conditions and that they are suitable for sterile drug production Specifically,

5Other quality system

A non-sterile tool was used in the production of drugs.

6Aseptic processing and sterility assurance

Disinfecting agents used in the ISO 5 area are not sterile.

7Other quality system

Apparent rust/discoloration was observed in the ISO 5 area.

8Other quality system

There is no cleaning of the dust-collecting areas in the area surrounding the ISO 5 area.

Similar findings at other companies

GRM selected findings from the same type of public document whose wording is close to a finding in this document. One per company.

A record as of the US FDA document published on 2024-01-17. Check the agency's announcements for any later corrective action, and rely on the original text. Translation and classification are machine-made.

Other records for this company

Option Care Enterprises Inc. findings history — including this company's other documentsAll US FDA findings US FDA documents, 2024 Go to Findings search
Weekly Newsletter

Get new findings like these every Monday

Every Monday we email the week's new findings and actions from the FDA, EMA, Health Canada and MFDS. Each one links to its record on our site, where you'll find the regulator's original document. We'll also let you know when the site gains new features. Unsubscribe any time with one click.

See recent findings first

Sent every Monday · a confirmation email follows when you subscribe · unsubscribe from the footer of any email.